Skip to main content
CTVA logo

Corteva Inc

Exchange: NYSESector: Basic MaterialsIndustry: Agricultural Inputs

New Corteva is a global leader in crop protection, differentiated by its comprehensive portfolio of innovative and sustainable solutions, including a fast-growing biologicals platform. The company will build on a proven track record of operational excellence, supply chain optimization, and regulatory expertise to help farmers protect yields and improve returns.

Did you know?

Generated $4.8 in free cash flow for every $1 of capital expenditure in FY25.

Current Price

$85.46

+1.97%

GoodMoat Value

$94.47

10.5% undervalued
Profile
Valuation (TTM)
Market Cap$57.75B
P/E52.79
EV$50.59B
P/B2.39
Shares Out675.73M
P/Sales3.32
Revenue$17.40B
EV/EBITDA18.84

Corteva Inc (CTVA) Valuation

GoodMoat Analysis

Based on data as of March 26, 2026

Corteva's valuation appears unfavourable for a value investor, with a high P/E multiple and a minimal margin of safety relative to its fair value estimate. The stock's price is near the GoodMoat Target, and its P/E significantly exceeds both the sector average and its own earnings growth profile. This suggests the market is pricing in significant future improvement not yet reflected in current financials.

Read full analysis
Based on the GoodMoat Investment Framework's valuation assessment, Corteva's current price of $82.03 offers a minimal margin of safety. The GoodMoat Target of $94.47 implies an upside of approximately 15.2%, which falls into the 'Marginal' band (10–20%) and does not meet the 20% threshold typically sought for a favourable valuation. The primary concern is the elevated P/E ratio of 50.7x, which is high for a value-oriented investment. This multiple is difficult to justify given the company's modest financial performance, including a -1.7% YoY revenue decline and a 4.5% Return on Equity. While the 5.1% Free Cash Flow Yield is a positive signal, the P/E far outpaces what would be reasonable for a low-growth, single-digit ROE business, even when compared to sector averages which are typically lower. For a value investor, the combination of a full valuation, minimal margin of safety, and weak current growth metrics makes the case challenging. The stock appears to be pricing in a substantial recovery or operational improvement that has not yet materialized in its reported numbers. Analysis based on data as of 2024-05-15.

CTVA Fair Value Estimate

$94.4710.5% undervalued

Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

CTVA Valuation Metrics

FCF$2.81B
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

CTVA Valuation & Fair Value Analysis

Corteva Inc (CTVA) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The GoodMoat Fair Value target for Corteva Inc is $94.47. The current stock price is $85.46, suggesting the stock is 10.5% undervalued.

The price-to-earnings (P/E) ratio is 52.79. Price-to-book ratio is 2.39. Price-to-sales ratio is 3.32. Enterprise value to EBITDA is 18.84. PEG ratio is 0.03.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Corteva Inc's intrinsic value.